These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23688200)

  • 21. [Effectiveness of scar split thickness skin graft combined with acellular allogeneic dermis in treatment of large deep II degree burn scar].
    Cui Z; Yang X; Shou J; Wang G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1502-4. PubMed ID: 25826895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scar outcome of children with partial thickness burns: A 3 and 6 month follow up.
    Gee Kee EL; Kimble RM; Cuttle L; Stockton KA
    Burns; 2016 Feb; 42(1):97-103. PubMed ID: 26546385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.
    Rashaan ZM; Krijnen P; van den Akker-van Marle ME; van Baar ME; Vloemans AF; Dokter J; Tempelman FR; van der Vlies CH; Breederveld RS
    Trials; 2016 Mar; 17(1):122. PubMed ID: 26945575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives.
    Ud-Din S; Volk SW; Bayat A
    Exp Dermatol; 2014 Sep; 23(9):615-9. PubMed ID: 24863070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Research in Animal Models of Burn-Related Hypertrophic Scarring.
    Domergue S; Jorgensen C; Noël D
    J Burn Care Res; 2015; 36(5):e259-66. PubMed ID: 25356852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burn scar and contracture management.
    Chapman TT
    J Trauma; 2007 Jun; 62(6 Suppl):S8. PubMed ID: 17556995
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring.
    Huang JS; Wang YH; Ling TY; Chuang SS; Johnson FE; Huang SS
    FASEB J; 2002 Aug; 16(10):1269-70. PubMed ID: 12153996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars.
    Hakvoort T; Altun V; van Zuijlen PP; de Boer WI; van Schadewij WA; van der Kwast TH
    Eur Cytokine Netw; 2000 Jun; 11(2):233-39. PubMed ID: 10903802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory responses, matrix remodeling, and re-epithelialization after fractional CO
    DeBruler DM; Blackstone BN; Baumann ME; McFarland KL; Wulff BC; Wilgus TA; Bailey JK; Supp DM; Powell HM
    Lasers Surg Med; 2017 Sep; 49(7):675-685. PubMed ID: 28489283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective evaluation of burn and post-surgical scars and the accuracy of subjective scar type judgment.
    Wang ZY; Zhang J; Lu SL
    Chin Med J (Engl); 2008 Dec; 121(24):2517-20. PubMed ID: 19187588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids.
    Cotellese R; Hu S; Belcaro G; Ledda A; Feragalli B; Dugall M; Hosoi M; Ippolito E
    Minerva Chir; 2018 Apr; 73(2):151-156. PubMed ID: 29623705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety, efficacy, and tolerability of a novel silicone gel dressing following dermatological surgery.
    Sandhofer M; Schauer P
    Skinmed; 2012; 10(6):S1-7. PubMed ID: 23346665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Surgical Scars.
    Lee Peng G; Kerolus JL
    Facial Plast Surg Clin North Am; 2019 Nov; 27(4):513-517. PubMed ID: 31587770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new therapeutic protocol for the treatment of keloid scars: a retrospective study.
    Boccara D; Serror K; Chatelain S; Chaouat M; Mimoun M; Azoulay L
    J Wound Care; 2021 Mar; 30(3):184-190. PubMed ID: 33729847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic burn scars: analysis of variables.
    Deitch EA; Wheelahan TM; Rose MP; Clothier J; Cotter J
    J Trauma; 1983 Oct; 23(10):895-8. PubMed ID: 6632013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermal Remodeling of Burn Scar by Fractional CO2 Laser.
    Lee SJ; Suh DH; Lee JM; Song KY; Ryu HJ
    Aesthetic Plast Surg; 2016 Oct; 40(5):761-8. PubMed ID: 27519176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of insulin from PLGA-alginate dressing stimulates regenerative healing of burn wounds in rats.
    Dhall S; Silva JP; Liu Y; Hrynyk M; Garcia M; Chan A; Lyubovitsky J; Neufeld RJ; Martins-Green M
    Clin Sci (Lond); 2015 Dec; 129(12):1115-29. PubMed ID: 26310669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective intra-individual evaluation of silk compared to Biobrane for the treatment of superficial burns of the hand and face.
    Schiefer JL; Arens E; Grigutsch D; Rath R; Hoffmann A; Fuchs PC; Schulz A
    Burns; 2017 May; 43(3):539-548. PubMed ID: 28043735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.